| Autophagy in neurodegenerative diseases: pathogenesis and therapy |
39 |
| Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline |
20 |
| Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? |
19 |
| CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue |
17 |
| Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice |
16 |
| Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes |
16 |
| Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis |
16 |
| Animal prion diseases: the risks to human health |
15 |
| Recent advances in the histo-molecular pathology of human prion disease |
15 |
| Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence |
14 |
| cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates |
14 |
| Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts |
14 |
| The genetic landscape of anaplastic pleomorphic xanthoastrocytoma |
13 |
| Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia |
13 |
| Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice |
12 |
| Multinodular and vacuolating neuronal tumors in epilepsy: dysplasia or neoplasia? |
12 |
| Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
11 |
| Oligodendroglial alpha-synucleinopathy-driven neuroinflammation in multiple system atrophy |
11 |
| Brain-derived and circulating vesicle profiles indicate neurovascular unit dysfunction in early Alzheimer's disease |
11 |
| Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features |
10 |
| Alexander disease: an astrocytopathy that produces a leukodystrophy |
10 |
| Axonal loss in the multiple sclerosis spinal cord revisited |
10 |
| Severe white matter astrocytopathy in CADASIL |
10 |
| Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation |
10 |
| Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration |
10 |
| Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice |
10 |
| Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra-high field magnetic resonance imaging |
10 |
| Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population |
9 |
| Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion |
9 |
| Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities |
9 |
| Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma |
9 |
| Clusterin contributes to early stage of Alzheimer's disease pathogenesis |
9 |
| Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas |
9 |
| The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology |
8 |
| Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies |
8 |
| Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis |
8 |
| TREM2 expression in the human brain: a marker of monocyte recruitment? |
8 |
| Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features |
8 |
| MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course |
7 |
| BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity |
7 |
| CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling |
7 |
| Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment |
7 |
| Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis |
6 |
| Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease |
6 |
| Neuronal Rho GTPase Rac1 elimination confers neuroprotection in a mouse model of permanent ischemic stroke |
6 |
| Genetic defects disrupting glial ion and water homeostasis in the brain |
6 |
| Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging |
6 |
| Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders |
6 |
| The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats |
6 |
| EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity |
6 |